STOK logo

Stoke Therapeutics, Inc. (STOK) Cash From Investing

Annual CFI:

-$107.47M-$213.42M(-201.44%)
December 31, 2024

Summary

  • As of today, STOK annual cash from investing is -$107.47 million, with the most recent change of -$213.42 million (-201.44%) on December 31, 2024.
  • During the last 3 years, STOK annual cash from investing has fallen by -$31.05 million (-40.63%).
  • STOK annual cash from investing is now -201.44% below its all-time high of $105.95 million, reached on December 31, 2023.

Performance

1-Year Change

-201.44%

3-Year Change

-40.63%

5-Year Change

-6477.42%

15-Year Change

-95010.62%

STOK Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

17.77%
STOK annual cash from investing is higher than 17.77% of companies in Healthcare sector

Range

All-Time High

$105.95M
STOK annual cash from investing is currently -201.44% below its historical high of $105.95 million

3-Year Low

-$107.47M
STOK annual cash from investing is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
STOK previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 24, 2026
STOK next annual earnings announcement is scheduled for Mar 24, 2026

OtherSTOKcash flow metrics

Annual CFF

$131.09M
STOK annual cash from financing is $131.09 million

Annual CFO

-$86.85M
STOK annual cash from operations is -$86.85 million

Annual FCF

-$87.05M
STOK annual free cash flow is -$87.05 million

Annual CAPEX

$203.00K
STOK annual capital expenditures is $203.00 thousand

Quarterly CFI:

$9.09M+$157.57M(+106.12%)
September 30, 2025

Summary

  • As of today, STOK quarterly cash from investing is $9.09 million, with the most recent change of +$157.57 million (+106.12%) on September 30, 2025.
  • Over the past year, STOK quarterly cash from investing has increased by +$39.10 million (+130.31%).
  • STOK quarterly cash from investing is now -86.48% below its all-time high of $67.26 million, reached on September 30, 2022.

Performance

3-Month Change

+106.12%

1-Year Change

+130.31%

3-Year Change

-86.48%

5-Year Change

+3480.67%

STOK Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

83.39%
STOK quarterly cash from investing is higher than 83.39% of companies in Healthcare sector

Range

All-Time High

$67.26M
STOK quarterly cash from investing is currently -86.48% below its historical high of $67.26 million

3-Year Low

-$148.48M
STOK quarterly cash from investing is currently +106.12% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
STOK previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 24, 2026
STOK next earnings announcement is scheduled for Mar 24, 2026

OtherSTOKcash flow metrics

Quarterly CFF

$3.12M
STOK quarterly cash from financing is $3.12 million

Quarterly CFO

-$30.37M
STOK quarterly cash from operations is -$30.37 million

Quarterly FCF

-$30.50M
STOK quarterly free cash flow is -$30.50 million

Quarterly CAPEX

$132.00K
STOK quarterly capital expenditures is $132.00 thousand

TTM CFI:

-$124.93M+$39.10M(+23.84%)
September 30, 2025

Summary

  • As of today, STOK TTM cash from investing is -$124.93 million, with the most recent change of +$39.10 million (+23.84%) on September 30, 2025.
  • Over the past year, STOK TTM cash from investing has dropped by -$31.41 million (-33.58%).
  • STOK TTM cash from investing is now -175.12% below its all-time high of $166.31 million, reached on June 30, 2023.

Performance

3-Month Change

+23.84%

1-Year Change

-33.58%

3-Year Change

-120.83%

5-Year Change

-8070.83%

STOK TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

14.2%
STOK TTM cash from investing is higher than 14.2% of companies in Healthcare sector

Range

All-Time High

$166.31M
STOK TTM cash from investing is currently -175.12% below its historical high of $166.31 million

3-Year Low

-$164.03M
STOK TTM cash from investing is currently +23.84% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
STOK previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 24, 2026
STOK next earnings announcement is scheduled for Mar 24, 2026

OtherSTOKcash flow metrics

TTM CFF

$5.62M
STOK TTM cash from financing is $5.62 million

TTM CFO

$52.85M
STOK TTM cash from operations is $52.85 million

TTM FCF

$52.37M
STOK TTM free cash flow is $52.37 million

TTM CAPEX

$480.00K
STOK TTM capital expenditures is $480.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

STOK Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-201.4%+130.3%-33.6%
3Y3 Years-40.6%-86.5%-120.8%
5Y5 Years-6477.4%+3480.7%-8070.8%

STOK Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-201.4%at low-86.5%+106.1%-175.1%+23.8%
5Y5-Year-201.4%at low-86.5%+106.1%-175.1%+41.1%
All-TimeAll-Time-201.4%at low-86.5%+106.1%-175.1%+41.1%

STOK Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
$9.09M(+106.1%)
-$124.93M(+23.8%)
Jun 2025
-
-$148.48M(-1189.2%)
-$164.03M(-58.0%)
Mar 2025
-
$13.63M(+1564.5%)
-$103.83M(+3.4%)
Dec 2024
-$107.47M(-201.4%)
$819.00K(+102.7%)
-$107.47M(-14.9%)
Sep 2024
-
-$30.00M(+66.0%)
-$93.52M(-91.2%)
Jun 2024
-
-$88.28M(-983.8%)
-$48.90M(-177.8%)
Mar 2024
-
$9.99M(-32.4%)
$62.85M(-40.7%)
Dec 2023
$105.95M(+330.9%)
$14.77M(+1.1%)
$105.95M(-6.8%)
Sep 2023
-
$14.62M(-37.7%)
$113.67M(-31.7%)
Jun 2023
-
$23.47M(-55.8%)
$166.31M(+16.3%)
Mar 2023
-
$53.09M(+136.0%)
$142.99M(+411.6%)
Dec 2022
-$45.88M(+40.0%)
$22.49M(-66.6%)
-$45.88M(+18.9%)
Sep 2022
-
$67.26M(>+9900.0%)
-$56.58M(+56.2%)
Jun 2022
-
$146.00K(+100.1%)
-$129.10M(+39.1%)
Mar 2022
-
-$135.78M(-1251.0%)
-$212.00M(-177.4%)
DateAnnualQuarterlyTTM
Dec 2021
-$76.43M(-7178.7%)
$11.80M(+324.1%)
-$76.43M(+13.5%)
Sep 2021
-
-$5.26M(+93.6%)
-$88.31M(-6.0%)
Jun 2021
-
-$82.75M(>-9900.0%)
-$83.32M(>-9900.0%)
Mar 2021
-
-$204.00K(-126.7%)
-$644.00K(+38.7%)
Dec 2020
-$1.05M(+35.7%)
-$90.00K(+66.5%)
-$1.05M(+31.3%)
Sep 2020
-
-$269.00K(-232.1%)
-$1.53M(+17.0%)
Jun 2020
-
-$81.00K(+86.7%)
-$1.84M(+14.4%)
Mar 2020
-
-$610.00K(-7.2%)
-$2.15M(-31.8%)
Dec 2019
-$1.63M(-76.6%)
-$569.00K(+2.4%)
-$1.63M(-53.4%)
Sep 2019
-
-$583.00K(-48.7%)
-$1.06M(-121.0%)
Jun 2019
-
-$392.00K(-335.6%)
-$482.00K(-435.6%)
Mar 2019
-
-$90.00K(-246.2%)
-$90.00K(-246.2%)
Dec 2018
-$925.00K(-718.6%)
-
-
Mar 2018
-
-$26.00K
-$26.00K
Dec 2017
-$113.00K
-
-

FAQ

  • What is Stoke Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Stoke Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Stoke Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. TTM cash from investing year-on-year change?

What is Stoke Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of STOK is -$107.47M

What is the all-time high annual cash from investing for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high annual cash from investing is $105.95M

What is Stoke Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, STOK annual cash from investing has changed by -$213.42M (-201.44%)

What is Stoke Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of STOK is $9.09M

What is the all-time high quarterly cash from investing for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high quarterly cash from investing is $67.26M

What is Stoke Therapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, STOK quarterly cash from investing has changed by +$39.10M (+130.31%)

What is Stoke Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of STOK is -$124.93M

What is the all-time high TTM cash from investing for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high TTM cash from investing is $166.31M

What is Stoke Therapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, STOK TTM cash from investing has changed by -$31.41M (-33.58%)
On this page